<DOC>
	<DOCNO>NCT00113100</DOCNO>
	<brief_summary>The purpose study investigate way estrogen improve appearance sun damage human skin . Accumulating evidence suggest estrogen , take post menopausal woman , may cause skin look young consequence reduce wrinkle . Collagen abundant protein human skin give skin strength shape . Recent data indicate short-term topical estrogen ( 17-beta estradiol ) treatment increase collagen production sun damage skin . This study compare molecular microscopic effect topical 17-beta estradiol ( E2 ) apply skin short-term duration . It anticipate new knowledge study enable development new way improve function age skin .</brief_summary>
	<brief_title>Mechanisms Skin Repair Topical Estrogen</brief_title>
	<detailed_description>The objective study determine topically-applied 17-beta estradiol ( E2 ) , alone combination clobetasol , produce histological molecular effect distinguishable vehicle human skin . Specifically , study focus regulation collagen , elastin , hyaluronic acid production degradation human skin , steroid hormone receptor activate estrogen clobetasol . The site treat buttock , hip , forearm , facial skin . Subjects receive one twelve vehicle ( match solution without active ingredient ) , estrogen , and/or clobetasol topical application . Skin biopsy treat area obtain baseline subsequent timepoints . The study last two week . Endpoints include protein mRNA level collagen , elastin , hyaluronic acid , component skin connective tissue . In addition , perform cDNA microanalysis determine estrogen/clobetasol target gene human skin . The result study provide new knowledge regard molecular basis skin age . This new knowledge enable development new way improve function age skin .</detailed_description>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Healthy postmenopausal ( without spontaneous menstrual bleeding least 1 year ) woman , men , least 50 year age racial/ethnic type . Subjects must understand sign inform consent prior participation . Subjects must generally good health . Subjects must available followup visit comply requirement protocol . Not estrogen replacement therapy within past 3 month . No nonsteroidal antiinflammatory drug two week prior study entry . No topical steroid two week prior study entry . You must live within reasonable drive distance Ann Arbor , Michigan , and/or able attend schedule appointment study . History keloid formation hypertrophic scarring . History reaction lidocaine anesthetic . Subjects significant medical history concurrent condition investigator ( ) feel safe study participation would impair evaluation test site .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>skin</keyword>
	<keyword>estrogen</keyword>
	<keyword>sun damage</keyword>
	<keyword>Photodamaged Skin</keyword>
</DOC>